MIF-induced CD74+ microglia/macrophages are clinically relevant disease-associated subpopulations in brain metastasis and other CNS disorders

作者
Laura Álvaro‐Espinosa,Ángel Márquez-Galera,Neibla Priego,Virginia García-Calvo,María Perea-García,Carolina Hernández-Oliver,Diana Retana,Oliva Sánchez,Ana de Pablos-Aragoneses,Pedro García‐Gómez,Osvaldo Graña‐Castro,Óscar Lapuente-Santana,Fátima Al‐Shahrour,Ana Cayuela,Isabel Peset,Diego Megı́as,Mihaela Ola,Damir Varešlija,Leonie S. Young,Yolanda Martí-Mateos
标识
DOI:10.1101/2025.09.06.673623
摘要

Abstract The upregulation of CD74, a chaperone involved in MHC-II antigen processing 1,2 , has been broadly reported in virtually all brain disorders analyzed by single-cell RNA sequencing 3–6 . However, its expression is usually interpreted as indicative of antigen presentation. In parallel, CD74 expression has also been described in cancer cells across multiple tumor types, but interestingly in glioma its expression has been mainly identified in the microenvironment. However, the functional contribution of CD74 to disease progression in the brain, and specifically in secondary brain tumors, has not been directly addressed. Here we described that, in contrast to what it has been assumed, the presence of CD74 + microglia/macrophages, which is induced by increased levels of interferon gamma in the brain affected by metastases, does not relate to its canonical pathway. Instead, CD74’s alternative function as cytokine receptor is pivotal. Rewired by increasing levels of its ligand MIF, produced by proliferating cancer cells, the CD74 receptor, upon binding to this ligand, translocates to the nucleus activating a NF-κB-dependent program promoting metastasis progression. A brain metastasis-associated CD74 signature involves a more aggressive progression of the local disease in patients, while it has no clinical correlation with the matched primary tumor. Furthermore, we identified the CD74 + myeloid population in additional brain disorders including Alzheimer’s disease and multiple sclerosis, which shared a pan-disease non-canonical signature with clinical relevance. The brain-penetrant drug ibudilast, which prevents the binding of MIF to CD74, decreases brain metastases in experimental models in vivo and in patient-derived organotypic cultures ex vivo in a primary tumor-agnostic manner. Our findings suggest that MIF/CD74-induced reprogramming of myeloid cells in brain disorders is a novel vulnerability that could be exploited therapeutically against brain metastases, and possibly other brain disorders, guided by a non-invasive molecular strategy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
好名发布了新的文献求助10
1秒前
脱羰甲酸发布了新的文献求助10
3秒前
3秒前
赛Pierce完成签到,获得积分10
4秒前
4秒前
6秒前
开心鬼完成签到 ,获得积分20
6秒前
苗永悦发布了新的文献求助40
8秒前
驰驰完成签到,获得积分10
8秒前
wg发布了新的文献求助10
8秒前
Akim的应助被赛Pierce采纳,获得10
9秒前
无所事事发布了新的文献求助10
9秒前
9秒前
10秒前
12秒前
开心鬼关注了科研通微信公众号
12秒前
Rio完成签到,获得积分10
12秒前
liu123479完成签到,获得积分10
14秒前
Jasper的应助被863采纳,获得10
15秒前
Dawn发布了新的文献求助10
15秒前
16秒前
顾矜的应助被陆豪杰采纳,获得10
16秒前
jas完成签到 ,获得积分10
16秒前
Ren的应助被daomaihu采纳,获得100
17秒前
17秒前
Ren的应助被daomaihu采纳,获得100
17秒前
17秒前
脑洞疼的应助被daomaihu采纳,获得100
17秒前
研友_Y59785发布了新的文献求助10
17秒前
Ren的应助被daomaihu采纳,获得100
17秒前
Ren的应助被daomaihu采纳,获得100
17秒前
17秒前
18秒前
guoguozhijia158完成签到,获得积分10
18秒前
陈陌与发布了新的文献求助10
18秒前
limengkai完成签到,获得积分10
20秒前
SONG发布了新的文献求助10
21秒前
小栾完成签到,获得积分10
21秒前
22秒前
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188353
求助须知:如何正确求助?哪些是违规求助? 9576169
关于积分的说明 21845860
捐赠科研通 7786410
什么是DOI,文献DOI怎么找? 3435292
关于科研通互助平台的介绍 2559588
邀请新用户注册赠送积分活动 2482235